Clinical trial
Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating…
NCT00033293 · Children's Oncology Group, Other · Completed
Key facts
| NCT number | NCT00033293 |
|---|---|
| Title | Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma |
| Official title | A Phase III Randomized Trial of Intravenous Gammaglobulin Therapy for Patients With Neuroblastoma Associated Opsoclonus-Myoclonus-Ataxia Syndrome Treated With Chemotherapy and Prednisone |
| Lead sponsor | Children's Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4 Neuroblastoma, Stage 4S Neuroblastoma |
| Intervention type | Biological, Drug, Other, Procedure |
| Interventions | Clinical Observation, Cyclophosphamide, Laboratory Biomarker Analysis, Magnetic Resonance Imaging, Prednisone, Therapeutic Immune Globulin |
| Enrollment | 53 |
| Start date | Mar 15, 2004 |
| Primary completion | Dec 10, 2013 |
| Completion | Dec 31, 2022 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 18, 2023 |
| Countries | Australia, Canada, United States |
At a glance
- 100–999 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: